MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells

Journal of Surgical Oncology

Volumn 104, Issue 5, 2011, Pages 466-471

  Zhang, Xiaofang ^a   Wu, Xiaojuan ^a   Li, Juan ^b   Sun, Yanlin ^a   Gao, Peng ^a   Zhang, Cuijuan ^a   Zhang, Hui ^a   Zhou, Gengyin ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

breast cancer; glucosylceramide synthase; multidrug resistance; multidrug resistance gene 1

Indexed keywords

CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; COMPLEMENTARY DNA; DOXORUBICIN; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; URIDINE DIPHOSPHATE GLUCOSE; VINBLASTINE;

APOPTOSIS; ARTICLE; BREAST CELL; CANCER CELL; CELL SURVIVAL; CONCENTRATION RESPONSE; CYTOTOXICITY; FLOW CYTOMETRY; GENETIC TRANSFECTION; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CERAMIDES; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GLUCOSYLTRANSFERASES; HUMANS; P-GLYCOPROTEIN; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; VINBLASTINE;

EID: 79961060309     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21958     Document Type: Article

References (26)

1. Gouaze V, Yu JY, Bleicher RJ, et al.: Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. Mol Cancer Ther 2004; 3: 633-639. (Pubitemid 39193742)
2. Lavie Y, Cao H, Bursten SL, et al.: Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem 1996; 271: 19530-19536. (Pubitemid 26271630)
3. Lucci A, Cho WI, Han TY, et al.: Glucosylceramide: A marker for multiple-drug resistant cancers. Anticancer Res 1998; 18: 475-480. (Pubitemid 28174859)
4. Yamashita T, Wada R, Sasaki T, et al.: A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci USA 1999; 96: 9142-9147. (Pubitemid 29374721)
5. Liu YY, Han TY, Giuliano AE, et al.: Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem 1999; 274: 1140-1146.
6. Liu YY, Han TY, Giuliano AE, et al.: Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem 2000; 275: 7138-7143. (Pubitemid 30146262)
7. Liu YY, Han TY, Giuliano AE, et al.: Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J 2001; 15: 719-730. (Pubitemid 32245990)
8. Liscovitch M, Ravid D:, A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells. Cancer Lett 2007; 245: 350-352. (Pubitemid 44959366)
9. Zhang X, Li J, Qiu Z, et al.: Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi). Cancer Biol Ther 2009; 8: 1117-1121.
10. Ueda K, Cardarelli C, Gottesman MM, et al.: Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 1987; 84: 3004-3008. (Pubitemid 17064766)
11. van Helvoort A, Giudici ML, Thielemans M, et al.: Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis, where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity. J Cell Sci 1997; 110: 75-83. (Pubitemid 27057946)
12. Smyth MJ, Krasovskis E, Sutton VR, et al.: The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci USA 1998; 95: 7024-7029.
13. Sun Y, Zhang T, Gao P, et al.: Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs. Breast Cancer Res Treat 2010; 121: 591-599.
14. Li CB, Zhang F, Shi YR, et al.: Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA. Ai Zheng 2004; 23: 1605-1610.
15. Klappe K, Hinrichs JW, Kroesen BJ, et al.: MRP1 and glucosylceramide are coordinately over expressed and enriched in rafts during multidrug resistance acquisition in colon cancer cells. Int J Cancer 2004; 110: 511-522. (Pubitemid 38658016)
16. Gao P, Zhou GY, Guo LL, et al.: Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter. Cancer Lett 2007; 256: 81-89. (Pubitemid 47333334)
17. Kaszubiak A, Holm PS, Lage H:, Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes. Int J Oncol 2007; 31: 419-430.
18. Veldman RJ, Klappe K, Hinrichs J, et al.: Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus. FASEB J 2002; 16: 1111-1113.
19. Bleicher RJ, Cabot MC:, Glucosylceramide synthase and apoptosis. Biochim Biophys Acta 2002; 1585: 172-178. (Pubitemid 36092082)
20. Lavie Y, Cao H, Volner A, et al.: Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem 1997; 272: 1682-1687. (Pubitemid 27043253)
21. Olshefski RS, Ladisch S:, Glucosylceramide synthase inhibition enhances vincristine-induced cytotoxicity. Int J Cancer 2001; 93: 131-138. (Pubitemid 32539512)
22. Shukla A, Shukla GS, Radin NS:, Control of kidney size by sex hormones: Possible involvement of glucosylceramide. Am J Physiol 1992; 262: F24-F29.
23. Abe A, Radin NS, Shayman JA:, Induction of glucosylceramide synthase by synthase inhibitors and ceramide. Biochim Biophys Acta 1996; 1299: 333-341.
24. Shabbits JA, Mayer LD:, P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs. Mol Cancer Ther 2002; 1: 205-213.
25. Ruckhaberle E, Karn T, Hanker L, et al.: Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer. J Cancer Res Clin Oncol 2009; 135: 81-90.
26. Liu YY, Gupta V, Patwardhan GA, et al.: Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling. Mol Cancer 2010; 9: 145.